Cel-Sci Corporation
CVMCel-Sci Corporation (CVM) is a biotechnology company focused on developing immunotherapy treatments for cancer and other diseases. Known for its flagship product, Multikine, a cytokine-based immunotherapy aimed at boosting the immune response against tumors, Cel-Sci aims to improve therapeutic options for patients with various cancers. The company also engages in research and development of other immunomodulatory therapies.
Company News
The article discusses three emerging growth stock ideas from the 2024 Think Equity Conference, including Cel-Sci, NetSol Technologies, and United States Antimony Corporation.
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit. U Power shares dipped 54% to $0.7090 on Monday. Here are some other stocks moving in today's mid-day session. Gainers EyePoint Pharm...
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. The Singing Machine Company, Inc. (NASDAQ: MICS) shares surged 32% to $2.10 after the company announced it launched a new party accessory product line available at Walmart. Biophytis S.A. (NASDAQ: BPT...
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 70 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 34,655.10 while the NASDAQ fell 0.38% to 14,190.20. The S&P 500, also fell, declining, 0.05% to 4,520.47. Check This Out: Ethereum Slides But Remains Above $1,900; 1inch Network Becomes T...
Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares gained 41.8% to $0.3729 in pre-market trading after EMA announced positive feedb...
